CSPT Storage, Handling, and Transport 5 — Questions and Answers
Question 1: A pharmacy receives a shipment of CSPs that were shipped with a temperature monitor showing a 4-hour excursion to 35°C. What should occur?
- Accept the shipment and store normally
- Accept but shorten the BUD by half
- Reject or quarantine and contact the compounding facility for evaluation (Correct answer)
- Discard immediately without documentation
Correct answer: Reject or quarantine and contact the compounding facility for evaluation
A documented temperature excursion requires rejection or quarantine and evaluation by the compounding facility to assess product integrity.
Question 2: Segregated storage of hazardous drugs from non-hazardous drugs in a pharmacy is required to:
- Improve inventory turnover rates
- Prevent accidental selection and cross-contamination (Correct answer)
- Meet DEA controlled substance regulations
- Reduce pharmacy refrigerator costs
Correct answer: Prevent accidental selection and cross-contamination
Physical segregation of hazardous drugs prevents accidental dispensing errors and cross-contamination of non-hazardous products.
Question 3: What type of personal protective equipment (PPE) is required when unpacking hazardous drug shipments?
- No PPE is required for intact sealed packages
- Gloves only
- Chemotherapy-rated gloves and a gown at minimum (Correct answer)
- Full respirator and face shield only
Correct answer: Chemotherapy-rated gloves and a gown at minimum
USP <800> requires at minimum chemotherapy-rated gloves and a gown when receiving hazardous drug shipments due to potential surface contamination.
Question 4: How should a CSP labeled 'Do Not Shake' be handled during transport within a facility?
- Place in a pneumatic tube system for rapid delivery
- Carry upright and avoid any agitation or mixing motion (Correct answer)
- Store horizontally to prevent settling
- Invert the bag twice before transport to mix contents
Correct answer: Carry upright and avoid any agitation or mixing motion
Preparations labeled 'Do Not Shake' must be transported without agitation to prevent emulsion breakdown, precipitation, or particle formation.
Question 5: Which of the following best describes a 'beyond-use date' (BUD) in the context of CSP storage?
- The manufacturer's expiration date printed on the original drug vial
- The date and time after which the CSP should not be used, assigned by the compounder (Correct answer)
- The last date the CSP can be refrigerated before freezing is required
- The date when quality testing must be repeated
Correct answer: The date and time after which the CSP should not be used, assigned by the compounder
A BUD is the date/time assigned by the compounder based on stability data and storage conditions, after which the CSP must not be used.
Question 6: A CSP stored in the refrigerator develops visible particulate matter. The correct action is to:
- Filter the preparation before dispensing
- Warm the vial to see if particulates dissolve
- Quarantine and do not dispense; investigate and document (Correct answer)
- Dispense with a warning label about visible particles
Correct answer: Quarantine and do not dispense; investigate and document
Visible particulate matter is a quality failure indicator requiring quarantine, investigation, and documentation — the CSP must not be dispensed.
Question 7: When storing multiple CSPs of the same drug in a refrigerator, which practice is essential for preventing medication errors?
- Arrange vials by size from smallest to largest
- Use first-in, first-out (FIFO) rotation based on BUD (Correct answer)
- Group all vials together regardless of BUD
- Store the most recently compounded batch at the front for easy access
Correct answer: Use first-in, first-out (FIFO) rotation based on BUD
FIFO rotation ensures that CSPs with the earliest BUD are used first, reducing waste and the risk of dispensing expired preparations.
A pharmacy receives a shipment of CSPs that were shipped with a temperature monitor showing a 4-hour excursion to 35°C.
What should occur?